Datoy, Merry .

HRN: 28-35-40  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/13/2026
CEFTRIAXONE 1G (VIAL)
02/13/2026
02/19/2026
IV
2g
Q24
Uti
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: